鳞状细胞肺癌孤立性肾转移的18F-FDG PET/CT表现
本文报告一例64岁男性鳞状细胞肺癌术后14个月出现孤立性肾转移的18F-FDG PET/CT表现。再分期PET/CT见肾皮质小灶性FDG摄取增高,初判为肾皮质示踪剂滞留,5个月后复查病灶更明显,根治性肾切除组织病理确诊为肾鳞状细胞癌转移。
要点
- 64岁男性鳞状细胞肺癌根治术后14个月,再分期PET/CT见肾皮质小灶FDG摄取增高。
- 初判为肾皮质示踪剂滞留,5个月后复查PET/CT病灶更明显。
- 根治性肾切除组织病理确诊为肾鳞状细胞癌转移。
核心结论
- 孤立性肾转移在再分期18F-FDG PET/CT上可表现为肾皮质小灶性FDG摄取增高。
研究设计与样本
- 病例报告,1例64岁男性鳞状细胞肺癌患者。
主要发现
- 患者14个月前因鳞状细胞肺癌行根治性手术,后接受化疗和免疫治疗。
- 再分期18F-FDG PET/CT见肾皮质小灶性FDG摄取增高,被视为肾皮质示踪剂滞留。
- 5个月后第二次PET/CT示肾转移灶更明显。
- 患者随后行根治性肾切除,组织病理确诊为肾鳞状细胞癌转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present the 18 F-FDG PET/CT findings of a 64-year-old man with isolated renal metastasis. He had a history of radical surgery for squamous cell lung cancer 14 months ago, followed by chemotherapy and immunotherapy. The renal metastasis presented as a small focus of increased FDG uptake in the restaging 18 F-FDG PET/CT scan, which was regarded as renal cortical tracer retention. The renal metastasis was more prominent on the second PET/CT performed 5 months later. The patient subsequently underwent radical nephrectomy, and histopathological examination confirmed the diagnosis of renal squamous cell carcinoma metastasis.
引用
- Yu J, Li Y, Yang X, et al. 18 F-FDG PET/CT Findings of Isolated Renal Metastasis From Squamous Cell Lung Cancer. Clin Nucl Med. 2024. PMID: 39441103. doi:10.1097/RLU.0000000000005545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。